Bacteriologic and therapeutic considerations in intra-abdominal surgical infections

Anaerobe

Volumn 3, Issue 2-3, 1997, Pages 207-212

  Giamarellou, Helen ^a   Kanellakopoulou, Kiki ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Antibiotics; Bacteroides fragilis; Peritontitis; Surgical infections

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; CEFOTETAN; CEFOXITIN; CEFTIZOXIME; CHLORAMPHENICOL; CILASTATIN; CILASTATIN PLUS IMIPENEM; CLAVULANIC ACID; CLINDAMYCIN; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; PENICILLIN G; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; SULBACTAM; SULTAMICILLIN; TAZOBACTAM; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ABDOMINAL INFECTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIUM CONTAMINATION; BACTEROIDES FRAGILIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; DEBRIDEMENT; DISEASE SEVERITY; DRUG CHOICE; DRUG EFFICACY; EARLY DIAGNOSIS; ENTEROCOCCUS; HUMAN; NONHUMAN; PERITONEUM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SURGICAL INFECTION;

BACTERIA (MICROORGANISMS); BACTEROIDES FRAGILIS; ENTEROCOCCUS; ENTEROCOCCUS SP.;

EID: 0031126402     PISSN: 10759964     EISSN: None     Source Type: Journal    
DOI: 10.1006/anae.1997.0107     Document Type: Conference Paper

References (37)

1. Finegold S. M., George W. L. Anaerobic Infections in Humans. 1989;Academic Press, San Diego.
2. Gorbach S. Antibiotic treatment of anaerobic infections. Clin Infect Dis. 18:1994;303-304.
3. Dellinger E. P. Intraabdominal infections: Treatment considerations. Inf Dis Clin Pract. 4:1995;163-169.
4. Nichols R. L., Smith J. W. Anaerobes from a surgical perspective. Clin Infect Dis. 18:1994;280-286.
5. Edmiston C. E., Walker A. P. Microbiology of intraabdominal infections. Inf Dis Clin Pract. 5:1996;15-19.
6. Nichols R. L. Management of intraabdominal sepsis. Am J Med. 80:1986;204-209.
7. Lennard E. S., Minshew B. H., Dellinger E. P., Wertz M. J., Heimbach D. M., Counts G. W. et al. Stratified outcome comparison of clindamycin - gentamicin vs. chloramphenicol - gentamicin for treatment of intra-abdominal sepsis. Arch Surg. 120:1985;889-898.
8. Solomkin J. S., Dellinger G. P., Cristin N. V., Busuttil R. W. Results of a multicenter trail comparing imipenem cilastatin to tobramycin/clindamycin for intraabdominal infections. Ann Surg. 212:1990;581-591.
9. Christou N. V., Barie B. S., Dellinger E. P., Waymack J. P., Stone H. H. Surgical infection society intra-abdominal infection study. Prospective evaluation of management techniques and outcome. Arch Surg. 128:1993;193-199.
10. Mosdell D. M., Morris D. M., Voltura A., Pitcher D. W., Twiest M. W., Milne R. L. et al. Antibiotic treatment for surgical peritonitis. Ann Surg. 214:1991;543-552.
11. Bennion R. S., Baron E. J., Thompson J. E., Dawnes J., Summanen P., Talan D. A., Finegold S. M. The bacteriology of gangrenous and perforated appendicitis-revisited. Ann Surg. 211:1990;165-171.
12. Duerden B. J. Virulence factors in anaerobes. Clin Infect Dis. 18:1994;253-259.
13. Brook J. Enhancement of growth of aerobic and facultative bacteria in mixed infections with Bacteroides species. Infect Immun. 50:1985;929-931.
14. Finegold S., Summanen P., Gerardo S. H., Baron E. Clinical importance of Bilophila wodsworthia. Eur J Clin Microbiol Infect Dis. 11:1992;1058-1063.
15. Nichols R. L., Smith J. W. Wound and intra-abdominal infections: Microbiological considerations and approaches to treatment. Clin Infect Dis. 16:1993;266-272.
16. Condon R., Krepel C. J., Edmiston C. E. Antibiotic resistance among intra-abdominal pathogens. Inf Dis Clin Pract. 4:1995;150-155.
17. Rotstein O. D., Pruett T. L., Simmons R. I. Microbiologic features and treatment of persistent peritonitis in patients in the intensive care unit. Can J Surg. 29:1986;247-250.
18. Wilson S. E., Patel C. Penetrating abdominal trauma: Prevention of post injury infection. Inf Dis Clin Pract. 4:1995;156-162.
19. Weinstein W. M., Bartlett J. G., Gorbach S. L. Experimental intra-abdominal abscess in rats: development of an experimental model. Infect Immun. 10:1974;1250-1255.
20. Weinstein M. W., Onderdonk A. B., Bartlett J. G., Louie T. J., Gorbach S. L. Antimicrobial therapy of experimental intra-abdominal sepsis. J Infect Dis. 132:1975;282-286.
21. Phillips I., King A., Nord C. E., Hoffstedt B. on behalf of a European Study Group. Antibiotic sensitivity of the Bacteroides fragilis group in Europe. Eur J Clin Microbiol Infect Dis. 11:1992;292-304.
22. thnd.
23. Bohnen J. M.A., Solomkin J. S., Dellinger E. P., Bjornson H. S., Page C. P. Guidelines for clinical care:anti-infective agents for intra-abdominal infection. Arch Surg. 127:1992;83-89.
24. Berne T. V., Yellin A. W., Appleman M. D., Heseltine P. N. Antibiotic management of surgically treated gangrenous or perforated appendicitis. Comparison of gentamicin and clindamycin vs cefamandole vs cefoperazone. Am J Surg. 144:1982;8-13.
25. Malangoni M. A., Condon R. E., Spiegel C. A. Treatment of intra-abdominal infections is appropriate with single-agent or combination therapy. Surgery. 98:1985;648-655.
26. Gorbach S. L. Intra-abdominal infections. Clin Infect Dis. 17:1993;961-967.
27. Brismar B., Malborg A. S., Tunevall G., Wretlind B., Bergman L., Mentzing L. O. et al. Piperacillin-tazobactam vs. imipenem - cilastatin for treatment of intraabdominal infections. Antimicrob Agents Chemother. 36:1992;2766-2773.
28. Nichols R. L., Smith J. W., Waterman R. S., Michaels W. T., Garcia R. Y. Parenteral antibiotic usage for surgical infection: Report of a selective survey. Inf Dis Clin Pract. 5:1996;26-31.
29. Kanellakopoulou K., Giamarellou H., Papadothomakos P., Tsipras H., Chloroyiannis J., Theakou R., Sfikakis P. Meropenem, a new carbapenem, versus imipenem - cilastatin in intraabdominal surgical infections. Eur J Clin Microb Infect Dis. 12:1993;449-453.
30. Skau T., Nystrom P., Carlsson C. Severity of illness in intra-abdominal infection. A comparison of two indexes. Arch Surv. 120:1985;152-158.
31. Nystrom P. O., Bax R., Dellinger E. P., Dominioni L., Knaus W. A., Meakins J. L. et al. Proposed definitions for diagnosis severity scoring, stratification, and outcome for trials on intra-abdominal infection. World J Surg. 14:1990;148-158.
32. Solomkin J. S., Meaking J. L., Allo M. D., Dellinger E. P., Simmons R. L. Antibiotic trials in intra-abdominal infections: a critical evaluation of study design and outcome reporting. Ann Surg. 200:1984;29-39.
33. Bohnen, J. M.A. Mustard, R. A. Schouten, B. D. Steroids, APACHE II score, and the outcome of abdominal infection, Arch Surg, 129, 33, 38.
34. Condon R. E. Current antibiotic-related tissues in treatment of appendicitis. Inf Dis Clin Pract. 5:1996;2-8.
35. Finegold S. M. Anaerobes: Problems and controversies in bacteriology, infections and susceptibility testing. Rev Infect Dis. 12:1990;223-230.
36. Hemming A., Davis N. I., Robins R. E. Surgical versus percutaneous drainage of intra-abdominal abscesses. Am J Surg. 161:1991;593-595.
37. Wilson S. E., Hopkins J. A. Clinical correlates of anaerobic bacteriology in peritonitis. Clin Inf Dis. 20:1995;251-256.